Clinical Trials Directory

Trials / Completed

CompletedNCT01100671

Comparison of 18F-fluorodeoxyglucose Positron Emission Tomography and Coronary Computed Tomography in Assessing Vascular Inflammation

Comparison of 18F-fluorodeoxyglucose Positron Emission Tomography and Coronary Computed Tomography in Assessing Vascular Inflammation in Healthy Population

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Korea University · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

Vascular inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising tool for identifying and quantifying vascular inflammation within atherosclerotic plaques.cardiac multidetector-row CT can provide measurements of coronary artery calcium (CAC), the degree of stenosis, and the characteristics of plaque including its potential vulnerability. Therefore, the purpose of the investigators study is to compare the usefulness of 18 FDG-PET and MDCT in assessing the vascular inflammatory status and vulnerability.

Conditions

Interventions

TypeNameDescription
OTHERCross section studyThis is not intervention study. The purpose of the study is to examine the relationship of vascular inflammation assessed by 18FDG-PET and MDCT at the cross section setting

Timeline

Start date
2010-04-01
Primary completion
2011-07-01
Completion
2011-08-01
First posted
2010-04-09
Last updated
2018-03-14

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01100671. Inclusion in this directory is not an endorsement.